Google
×
Including results for mirati investor relations
Search only for mrtx investor relations
The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of ...
Oct 8, 2023 · In connection with the proposed acquisition of Mirati by Bristol Myers Squibb, Mirati intends to file a preliminary and definitive proxy ...
At Mirati, we are relentlessly focused on developing best-in-class targeted therapies to meaningfully impact the lives of patients with cancer.
The Investor Relations website contains information about Altamira Therapeutics's business for stockholders, potential investors, and financial analysts.
Missing: mrtx | Show results with:mrtx
People also ask
This presentation includes forward-looking statements regarding Mirati's business, financial guidance and the therapeutic and commercial.
Missing: relations | Show results with:relations
(Nasdaq: MRTX) today announced that it intends to ... Mirati Therapeutics (NASDAQ: MRTX) is a San Diego-based ... Investor Relations and Media Contact: Temre ...
Oct 8, 2023 · (NASDAQ: MRTX) today announced that they ... Use of Non-GAAP Financial Information and Financial Guidance ... investor.relations@bms.com. Mirati ...
Mar 24, 2023 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
MRTX on Nasdaq. This company's Exchange Act ... [+] 10-K (annual reports) and 10-Q (quarterly reports) ... Before you Invest, Investor.gov. Get answers to your ...
Missing: relations | Show results with:relations
Nov 6, 2023 · (NASDAQ: MRTX), a commercial stage ... Investor Relations: ir@mirati.com. Media ... 183,243. 206,131. Shareholders' equity. 946,465. 996,516. Total ...